ACR Appropriateness Criteria® Penetrating Trauma-Lower Abdomen and Pelvis.


Journal

Journal of the American College of Radiology : JACR
ISSN: 1558-349X
Titre abrégé: J Am Coll Radiol
Pays: United States
ID NLM: 101190326

Informations de publication

Date de publication:
Nov 2019
Historique:
received: 15 05 2019
accepted: 16 05 2019
entrez: 6 11 2019
pubmed: 7 11 2019
medline: 21 10 2020
Statut: ppublish

Résumé

Lower urinary tract injury is most commonly the result of blunt trauma but can also result from penetrating or iatrogenic trauma. Clinical findings in patients with a mechanism of penetrating trauma to the lower urinary tract include lacerations or puncture wounds of the pelvis, perineum, buttocks, or genitalia, as well as gross hematuria or inability to void. CT cystography or fluoroscopy retrograde cystography are usually the most appropriate initial imaging procedures in patients with a mechanism of penetrating trauma to the lower urinary tract. CT of the pelvis with intravenous contrast, pelvic radiography, fluoroscopic retrograde urethrography, and CT of the pelvis without intravenous contrast may be appropriate in some cases. Arteriography, radiographic intravenous urography, CT of the pelvis without and with intravenous contrast, ultrasound, MRI, and nuclear scintigraphy are usually not appropriate. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment.

Identifiants

pubmed: 31685107
pii: S1546-1440(19)30612-X
doi: 10.1016/j.jacr.2019.05.023
pii:
doi:

Substances chimiques

Contrast Media 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

S392-S398

Informations de copyright

Copyright © 2019 American College of Radiology. Published by Elsevier Inc. All rights reserved.

Auteurs

Matthew T Heller (MT)

University of Pittsburgh, Pittsburgh, Pennsylvania. Electronic address: heller.matthew@mayo.edu.

Aytekin Oto (A)

Panel Chair, University of Chicago, Chicago, Illinois.

Brian C Allen (BC)

Panel Vice-Chair, Duke University Medical Center, Durham, North Carolina.

Oguz Akin (O)

Memorial Sloan Kettering Cancer Center, New York, New York.

Lauren F Alexander (LF)

Mayo Clinic, Jacksonville, Florida.

Jaron Chong (J)

McGill University, Montreal, Quebec, Canada.

Adam T Froemming (AT)

Mayo Clinic, Rochester, Minnesota.

Pat F Fulgham (PF)

Urology Clinics of North Texas, Dallas, Texas, American Urological Association.

David C Mackenzie (DC)

Maine Medical Center, Portland, Maine, American College of Emergency Physicians.

Jodi K Maranchie (JK)

UPMC, Pittsburgh, Pennsylvania, American Urological Association.

Rekha N Mody (RN)

Cleveland Clinic, Cleveland, Ohio.

Bhavik N Patel (BN)

Stanford University Medical Center, Stanford, California.

Nicola Schieda (N)

Ottawa Hospital Research Institute and the Department of Radiology, The University of Ottawa, Ottawa, Ontario, Canada.

Ismail B Turkbey (IB)

National Institutes of Health, Bethesda, Maryland.

Aradhana M Venkatesan (AM)

The University of Texas MD Anderson Cancer Center, Houston, Texas.

Carolyn L Wang (CL)

University of Washington, Seattle Cancer Care Alliance, Seattle, Washington.

Mark E Lockhart (ME)

Specialty Chair, University of Alabama at Birmingham, Birmingham, Alabama.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH